Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps
Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests
Gleevec Better Than Interferon For Newly Diagnosed CML
Two-Drug Combination Extends Survival Of Mesothelioma
Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers
Two-Month Survival Benefit For Some NSCLC Patients
Cancer Cases To Double By 2050, Annual Report Says
Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds
St. John’s Wort Not Indicated For Patients On Irinotecan
Large Pregnancy Weight Gain Raises Risk For Breast Cancer
Clinical Trials Approved Last Month By NCI’s CTEP
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
